C. Beuscart

1.9k total citations
51 papers, 846 citations indexed

About

C. Beuscart is a scholar working on Epidemiology, Pharmacology and Surgery. According to data from OpenAlex, C. Beuscart has authored 51 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 11 papers in Pharmacology and 8 papers in Surgery. Recurrent topics in C. Beuscart's work include Pneumonia and Respiratory Infections (13 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Antibiotic Use and Resistance (8 papers). C. Beuscart is often cited by papers focused on Pneumonia and Respiratory Infections (13 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Antibiotic Use and Resistance (8 papers). C. Beuscart collaborates with scholars based in France, Belgium and United States. C. Beuscart's co-authors include O. Leroy, G. Beaucaire, Hugues Georges, Y Mouton, Ch. Santré, Benoît Guéry, Christian Chidiac, Olivier Leroy, É. Senneville and C. Chidiac and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and European Heart Journal.

In The Last Decade

C. Beuscart

48 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Beuscart France 14 582 209 194 146 142 51 846
Lala M. Dunbar United States 16 465 0.8× 258 1.2× 104 0.5× 396 2.7× 176 1.2× 22 1.1k
F. Schlaeffer Israel 17 665 1.1× 60 0.3× 114 0.6× 131 0.9× 111 0.8× 37 973
D. Fontanals Spain 22 1.1k 1.8× 103 0.5× 202 1.0× 272 1.9× 248 1.7× 57 1.5k
Y. Péan France 15 417 0.7× 327 1.6× 129 0.7× 283 1.9× 240 1.7× 38 998
Claudette Muller‐Serieys France 18 335 0.6× 255 1.2× 71 0.4× 197 1.3× 337 2.4× 40 806
Micheline Roussel‐Delvallez France 16 444 0.8× 113 0.5× 413 2.1× 188 1.3× 196 1.4× 19 1.1k
Barbara A. Wiesinger United States 10 666 1.1× 284 1.4× 132 0.7× 197 1.3× 183 1.3× 12 838
R. R. Muder United States 12 364 0.6× 86 0.4× 203 1.0× 251 1.7× 183 1.3× 13 954
Zoe Athanassa Greece 11 385 0.7× 150 0.7× 176 0.9× 112 0.8× 165 1.2× 15 621
Ernesto G. Scerpella United States 16 476 0.8× 153 0.7× 242 1.2× 527 3.6× 198 1.4× 28 1.1k

Countries citing papers authored by C. Beuscart

Since Specialization
Citations

This map shows the geographic impact of C. Beuscart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Beuscart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Beuscart more than expected).

Fields of papers citing papers by C. Beuscart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Beuscart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Beuscart. The network helps show where C. Beuscart may publish in the future.

Co-authorship network of co-authors of C. Beuscart

This figure shows the co-authorship network connecting the top 25 collaborators of C. Beuscart. A scholar is included among the top collaborators of C. Beuscart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Beuscart. C. Beuscart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
May, Thierry, C. Beuscart, Véronique Vincent, et al.. (1997). Comparison of Combination Therapy Regimens for Treatment of Human Immunodeficiency Virus–Infected Patients with Disseminated Bacteremia Due toMycobacterium avium. Clinical Infectious Diseases. 25(3). 621–629. 37 indexed citations
3.
Millaire, A, O. Leroy, Pascal de Groote, et al.. (1997). Incidence and prognosis of embolic events and metastatic infections in infective endocarditis. European Heart Journal. 18(4). 677–684. 43 indexed citations
4.
Santré, Ch., O. Leroy, M. Roussel‐Delvallez, et al.. (1996). Reliability of Quantitative Cultures of Protected Specimen Brush After Freezing. American Journal of Respiratory and Critical Care Medicine. 153(2). 855–857. 6 indexed citations
5.
Leroy, O., Hugues Georges, C. Beuscart, et al.. (1996). Severe community-acquired pneumonia in ICUs: Prospective validation of a prognostic score. Intensive Care Medicine. 22(12). 1307–1314. 68 indexed citations
6.
Leroy, O., Alain Prat, Eric Decoulx, et al.. (1996). Fatal infection of coronary stent implantation. Catheterization and Cardiovascular Diagnosis. 39(2). 168–170. 57 indexed citations
7.
Alfandari, S., Christian Chidiac, É. Senneville, et al.. (1996). Imported malaria: presentation and outcome of 111 cases. Clinical Microbiology and Infection. 2(2). 86–90. 14 indexed citations
8.
Mauroy, Brigitte, C. Beuscart, J. Biserte, et al.. (1996). [Urinary infections in pregnant women].. PubMed. 6(4). 607–22. 2 indexed citations
9.
Leroy, O., Ch. Santré, C. Beuscart, et al.. (1995). A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Medicine. 21(1). 24–31. 212 indexed citations
10.
Santré, Ch., et al.. (1995). Amikacin levels in bronchial secretions of 10 pneumonia patients with respiratory support treated once daily versus twice daily. Antimicrobial Agents and Chemotherapy. 39(1). 264–267. 32 indexed citations
11.
Mouton, Y, et al.. (1995). Empirical monotherapy with meropenem in serious bacterial infections. Journal of Antimicrobial Chemotherapy. 36(suppl A). 145–156. 52 indexed citations
12.
Santré, Ch., O. Leroy, F. Fourrier, et al.. (1994). Paludisme grave : Apport de l'exsanguino-transfusion. Réanimation Urgences. 3(3). 241–248. 4 indexed citations
13.
Santré, Ch., Olivier Leroy, Marcel Simon, et al.. (1993). Pharmacokinetics of vancomycin during continuous hemodiafiltration. Intensive Care Medicine. 19(6). 347–350. 31 indexed citations
14.
15.
Mouton, Y, O. Leroy, C. Beuscart, et al.. (1993). Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections. Journal of Antimicrobial Chemotherapy. 31(suppl A). 87–95. 35 indexed citations
16.
Beaucaire, G., O. Leroy, C. Beuscart, et al.. (1991). Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections. Journal of Antimicrobial Chemotherapy. 27(suppl C). 91–103. 57 indexed citations
17.
Beuscart, C., et al.. (1990). Autocontrole de l'antibiotherapie. Evaluation d'un systeme de suivi informatise. Médecine et Maladies Infectieuses. 20(1). 25–32. 1 indexed citations
18.
Leroy, Olivier, et al.. (1989). Nosocomial infections associated with long-term radial artery cannulation. Intensive Care Medicine. 15(4). 241–246. 40 indexed citations
19.
Beuscart, C., O. Leroy, Éric Senneville, et al.. (1989). Utilisation de la ceftriaxone dans les infections bronchopulmonaires de reanimation. Médecine et Maladies Infectieuses. 19. 67–71. 1 indexed citations
20.
Beuscart, C., et al.. (1989). [Enterobacter, Serratia, Acinetobacter or Pseudomonas septicemias].. PubMed. 37(1). 39–42. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lala M. Dunbar Breakdown of academic impact, for papers by F. Schlaeffer Breakdown of academic impact, for papers by D. Fontanals Breakdown of academic impact, for papers by Y. Péan Breakdown of academic impact, for papers by Claudette Muller‐Serieys Breakdown of academic impact, for papers by Micheline Roussel‐Delvallez Breakdown of academic impact, for papers by Barbara A. Wiesinger Breakdown of academic impact, for papers by R. R. Muder Breakdown of academic impact, for papers by Zoe Athanassa Breakdown of academic impact, for papers by Ernesto G. Scerpella
Rankless by CCL
2026